Avalo Therapeutics, Inc. AVTX 23
Health Care · NASDAQ · Data as of 2026-08-06
Avalo Therapeutics, Inc. (AVTX) has delivered -30.3% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1956 of 1968 stocks overall and #259 of 260 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
23
Overall Rank
#1956 / 1968
Sector Rank
#259 / 260
Revenue CAGR
-30.3%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio